Your session is about to expire
← Back to Search
Nursing Care Model for Stroke
N/A
Waitlist Available
Led By Scott E Kasner, MD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights
Study Summary
This trial will study if having one nurse attend to a patient throughout their hospital stay will improve the quality of care and patient's health.
Eligible Conditions
- Mini Stroke
- Stroke
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Medication Compliance
Stroke Patient Education Retention Tool
Secondary outcome measures
Proportion of readmissions
Questionnaire to capture patient impression of their in-hospital care, transition home and quality of life
Stroke Impact Scale
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Attending nurse modelExperimental Treatment1 Intervention
The attending nurse model of in-hospital care delivery aims to improve patient understanding, shared decision making, medication adherence, and reduce early readmissions after discharge to improve quality of life. On the inpatient stroke unit, the attending nurse will take ownership of essential aspects of an individual stroke patient's care, education, and transition out of the hospital. To further contribute to the patient's plan of care, the attending nurse will be present on daily teaching rounds.
Group II: Conventional inpatient nursing careActive Control1 Intervention
Standard of care nursing care patients receive while inpatient
Find a Location
Who is running the clinical trial?
University of PennsylvaniaLead Sponsor
2,002 Previous Clinical Trials
42,880,329 Total Patients Enrolled
Scott E Kasner, MDPrincipal InvestigatorUniversity of Pennsylvania
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had bleeding in your brain, as seen on a head CT scan.You have had a temporary stroke-like episode caused by a lack of blood flow to the brain, but it has gotten better.You are currently receiving comfort or hospice care.You have serious memory and thinking problems before having a stroke.You are unable to communicate and do not have anyone to help you at home.You have had a stroke that caused a sudden weakness or difficulty speaking, likely due to a problem with blood flow in the brain.
Research Study Groups:
This trial has the following groups:- Group 1: Conventional inpatient nursing care
- Group 2: Attending nurse model
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies left in this research endeavor?
"The clinicaltrials.gov website outlines that this research project is not accepting any more patients. This program was first published on October 1st 2015 and last modified on January 19th 2023, however there are over 1100 other medical trials presently recruiting participants."
Answered by AI
Share this study with friends
Copy Link
Messenger